Previous 10 | Next 10 |
Helius Medical Technologies (HSDT) -17%.Avinger (AVGR) -12%.Cango (CANG) -11%.OncoCyte (OCX) -10%.Obalon Therapeutics (OBLN) -10%.Dolphin Entertainment (DLPN) -9%.Surgalign Holdings (SRGA) -8% after pricing equity offering at $1.50.Vertex Energy (VTNR) -7%.Atossa Therapeutics (ATOS)...
Precipio (PRPO) has signed agreements with two of the largest oncology practices in the US for the use of its Reagent Rental Program HemeScreen.During the coming weeks, both practices, West Cancer Center of Memphis and New York Cancer & Blood Speci...
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US, West Cancer Center of Memphis, TN; and New York Cancer & Blood S...
Precipio ([[PRPO]] +0.8%) entered into an agreement with a major U.S.-based oncology distributor to offer its HemeScreen POL program to its independent community oncology practices nationwide.Precipio estimates that an average practice participating in the Hemescreen POL program (depending on...
NEW HAVEN, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to offer Precipio’s HemeScreen POL (Physician Office Lab) program to its ind...
Precipio, Inc. (PRPO) Q3 2020 Results Conference Call November 19, 2020 05:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Presentation Operator Good day, and welcome to the Precipio Quarterly Shareholder Update Call. All participants will be in a listen-only mod...
NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q3-2020 corporate update call on Thursday, November 19 th at 5:00 PM ET. The call will include updates on the company’s current cor...
The vote count to decide the next U.S. commander-in-chief is ongoing but healthcare investors do not appear concerned about who will eventually prevail since most industries are up in lockstep with the broad market rally.Big Biopharma leaders: Eli Lilly ([[LLY]] +14.6%), AbbVie ([[ABBV]] +9.4...
SPI Energy (SPI) +56% on entering agreement with Shaanxi Tongjia Automobile.Anavex Life Sciences (AVXL) +36% after completing mid-stage study of lead drug in rare brain development disorder.Organogenesis Holdings (ORGO) +27% on Q3 preliminary results.Huttig Build...
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , along with its partner ADS Biotec announce the launch of the beta phase testing for its new IV-cell cytogenetics culturing media. Seven of A...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...